Talk:Cranial electrotherapy stimulation

message: The "regulation" section needs to be updated.  The FDA has reclassified CES devices as Class 2 for treatment of insomnia and anxiety.  It remains at Class 3 for treatment of depression.
https://www.massdevice.com/fda-reduces-controls-on-electrical-stimulation-devices-for-anxiety-insomnia/
The last paragraph of the "regulation" section is rather problematic. The titles of the four studies that are referred to (references 27, 28, 29, and 30 in the federal register document) in the quote, would indicate that these studies are not specifically intended to be evaluations of efficacy of CES for treatment of depressive disorders.
Regardless of what issues the FDA found with these studies, they are largely irrelevant to any discussion of clinical evidence supporting efficacy of CES for treatment of depressive mood disorders.  — Preceding unsigned comment added by 2601:249:603:B930:1CC3:B925:5B44:800C (talk) 16:24, 29 January 2021 (UTC)
thread_title:  Regulation update 

message: I would suggest that the Wikipedia editors should rethink the editorial consensus on CES regarding depression and probably other conditions as well.
The Cochrane review makes it's determination  based on 7 studies that were done more than 45 years ago.
An exact quote from this review is: 
"Randomized double-blind, sham-controlled trials of CES in people with rigorously diagnosed acute depression are needed."
So they recommend NOT abandoning CES, but validating it more rigorously. The original studies did indicate CES was effective despite certain deficiencies. The deficiencies they identified mostly consisted of inadequate screening of control and placebo groups as well as inadequate blinding. But it is quite feasible to remedy these issues. If they are remedied in new trials, wouldn't that be adequate? 
Fast forward to Jan 1, 2020.  More rigorous RCTs have been completed. The CMS grants a HCPCS code of  K1002 for CES.  The  CPT code is E1399.  Now treatment can be billed to insurance.  It is an acknowledgement that the treatment is proven to be effective. 
When the FDA was considering changing the category of CES technology in 2012, they held hearings.  They were trying to assess what they call "human experience".  
A particularly terse and adamant testimony was given by Stephen Xanakis MD Brigadier General US Army Ret. This can be found on youtube at:
https://www.youtube.com/watch?v=dYjq_-HLVz4&t=2s
Excerpts from Neurological Devices Panel of the Medical Devices Advisory Committee to the FDA found at:
https://www.youtube.com/watch?v=oYlmITFkueE
CES is found to be useful, effective, and necessary by professional clinicians working in stressful, front-line situations. Ignazs0581 (talk) 22:53, 3 February 2021 (UTC)
replies: text: Have you got any WP:MEDRS sources that say that? If so, then we could use them in the article. As it is though, the above wont be sufficient to make us update the article. -Roxy the happy dog . wooF 15:30, 4 February 2021 (UTC)
replies: text: Thanks. I am familiar with a lot of the ideas covered here but I will take the time to read it over carefully. Ignazs0581 (talk) 20:31, 4 February 2021 (UTC)
replies: text: You are welcome. That document is the one that governs how we define acceptable sources for medical content. You should, once you have "read it over carefully", use it to guide all your editing in medical areas of the project. -Roxy the grumpy dog . wooF 20:37, 4 February 2021 (UTC)
thread_title:  Maybe it is time for a reset